2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol(CAS: 274693-26-4)

This compound has a complex structure with a molecular weight of approximately 616.51 g/mol. It is highly soluble in organic solvents like DMSO and ethanol but less soluble in water. It is known for its reactivity in forming stable complexes with metal ions and its potential reactivity towards nucleophiles. Crystalline form is possible, though specific crystallographic details are not widely reported.

This compound is typically synthesized via a multi-step process involving the use of protected amino cyclopropanes, triazole coupling reactions, and alkylation steps. Specific catalysts like palladium and ligands are used to achieve high selectivity and yield. The exact details of the synthesis are highly proprietary and not widely published.

This compound is used in the pharmaceutical industry for its potential therapeutic applications. It can be found in the development of new drugs targeting specific biological pathways. While less common, it may also have applications in the polymer industry for developing novel materials and in the semiconductor industry for specific chemical processes.

Proper personal protective equipment (PPE) such as gloves, goggles, and a lab coat is essential when handling this compound. Work should be conducted in a fume hood to avoid inhalation. Spills should be cleaned up with appropriate absorbents, and the area should be well-ventilated. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.